GSA Capital Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-17,363
Closed -$372K 2050
2022
Q4
$372K Sell
17,363
-64,985
-79% -$1.39M 0.05% 796
2022
Q3
$1.48M Buy
+82,348
New +$1.08M 0.2% 57
2020
Q3
Sell
-20,686
Closed -$105K 1436
2020
Q2
$105K Buy
+20,686
New +$86.2K 0.06% 477
2018
Q3
Sell
-121,048
Closed -$330K 1987
2018
Q2
$330K Sell
121,048
-102,201
-46% -$282K 0.02% 1348
2018
Q1
$612K Buy
+223,249
New +$647K 0.03% 964
2017
Q1
Sell
-192,168
Closed -$928K 2059
2016
Q4
$928K Buy
192,168
+175,250
+1,036% +$5.2M 0.06% 597
2016
Q3
$780K Buy
+16,918
New +$954K 0.04% 773
2016
Q2
Sell
-13,371
Closed -$565K 1966
2016
Q1
$565K Sell
13,371
-3,537
-21% -$180K 0.04% 932
2015
Q4
$1.33M Buy
16,908
+2,743
+19% +$159K 0.07% 498
2015
Q3
$574K Buy
14,165
+6,942
+96% +$368K 0.03% 1045
2015
Q2
$376K Sell
7,223
-24,977
-78% -$1.24M 0.01% 1504
2015
Q1
$1.5M Buy
+32,200
New +$1.67M 0.06% 546
2014
Q4
Sell
-5,600
Closed -$218K 1951
2014
Q3
$218K Buy
+5,600
New +$220K 0.01% 1477

Other funds holding ISEE

GSA Capital Partners's ISEE Position: Q1 2023 in Review

GSA Capital Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 17,363 shares — an estimated $372K sold.

GSA Capital Partners first reported a position in ISEE in Q3 2014 and held it in 13 quarters. The position peaked at $1.5M in Q1 2015. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

  • GSA Capital Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • GSA Capital Partners sold 17,363 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $372K.
  • GSA Capital Partners first reported a position in IVERIC bio, Inc. Common Stock in Q3 2014 and held it in 13 quarters.
  • GSA Capital Partners's IVERIC bio, Inc. Common Stock position peaked at $1.5M in Q1 2015.
  • 223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.